Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Assets (2016 - 2025)

Surgery Partners (SGRY) has disclosed Assets for 12 consecutive years, with $8.1 billion as the latest value for Q4 2025.

  • Quarterly Assets rose 2.91% to $8.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 billion through Dec 2025, up 2.91% year-over-year, with the annual reading at $8.1 billion for FY2025, 2.91% up from the prior year.
  • Assets hit $8.1 billion in Q4 2025 for Surgery Partners, up from $7.9 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $8.1 billion in Q4 2025 to a low of $5.6 billion in Q2 2021.
  • Historically, Assets has averaged $6.9 billion across 5 years, with a median of $6.7 billion in 2022.
  • Biggest five-year swings in Assets: rose 16.07% in 2022 and later grew 2.91% in 2025.
  • Year by year, Assets stood at $6.1 billion in 2021, then grew by 9.23% to $6.7 billion in 2022, then rose by 2.91% to $6.9 billion in 2023, then rose by 14.74% to $7.9 billion in 2024, then rose by 2.91% to $8.1 billion in 2025.
  • Business Quant data shows Assets for SGRY at $8.1 billion in Q4 2025, $7.9 billion in Q3 2025, and $8.0 billion in Q2 2025.